FDA authorises updated (bivalent) COVID-19 vaccines for children down to 6 months of age

FDA

8 December 2022 - Today, the US FDA amended the emergency use authorisations of the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 vaccines to include use in children down to 6 months of age.

Read FDA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , US , Vaccine , Paediatrics , COVID-19